\nDou\u0103 tratamente existente au redus drastic num\u0103rul de decese cauzate de Ebola \u015fi ar trebui s\u0103 fie administrate persoanelor de toate v\u00e2rstele care sufer\u0103 de aceast\u0103 boal\u0103 hemoragic\u0103, adesea fatal\u0103, spune Organiza\u0163ia Mondial\u0103 a S\u0103n\u0103t\u0103\u0163ii.<\/p>\n
\nPublic\u00e2nd primele sale orient\u0103ri de p\u00e2n\u0103 acum cu privire la terapiile care trebuie utilizate \u00eempotriva Ebola, OMS a recomandat cu t\u0103rie, vineri, utilizarea a doi anticorpi monoclonali, mAb114, cunoscut \u015fi sub numele de Ansuvimab sau Ebanga, \u015fi REGN-EB3, sau Inmazeb, conform yahoo news.<\/p>\n
\nStudiile au ar\u0103tat c\u0103 cele dou\u0103 tratamente au “redus semnificativ mortalitatea”, a declarat Janet Diaz, \u015fefa unit\u0103\u0163ii de gestionare clinic\u0103 din cadrul programului de urgen\u0163e sanitare al OMS.<\/p>\n
\n\u00cen func\u0163ie de standardul de \u00eengrijire, ea a spus c\u0103 acestea ar putea salva \u00eentre 230 \u015fi 400 de vie\u0163i la fiecare 1.000 de persoane infectate.<\/p>\n
\n\u00cen orient\u0103rile sale, OMS a recomandat s\u0103 nu se utilizeze alte terapii care au fost testate pentru Ebola, inclusiv anticorpul monoclonal ZMapp \u015fi medicamentul antiviral Remdesivir.<\/p>\n
\nEbola este o febr\u0103 hemoragic\u0103 viral\u0103, adesea fatal\u0103, care a fost identificat\u0103 pentru prima dat\u0103 \u00een Africa Central\u0103 \u00een 1976. Boala a fost denumit\u0103 dup\u0103 un r\u00e2u din Republica Democratic\u0103 Congo, cunoscut pe atunci sub numele de Zair.<\/p>\n
\nCea mai grav\u0103 epidemie din Africa de Vest, \u00eentre 2013 \u015fi 2016, a ucis peste 11 300 de persoane. Republica Democratic\u0103 Congo a avut mai mult de o duzin\u0103 de epidemii, cea mai mortal\u0103 ucig\u00e2nd 2.280 de persoane \u00een 2020.<\/p>\n
\nRatele de fatalitate ale bolii, care se r\u0103sp\u00e2nde\u015fte prin fluidele corporale \u015fi provoac\u0103 febr\u0103 mare, v\u0103rs\u0103turi \u015fi hemoragii, pot ajunge la 80-90%, \u00een func\u0163ie de rapiditatea cu care este detectat\u0103 \u015fi tratat\u0103.<\/p>\n
\nOMS a declarat c\u0103 mAb114 \u015fi REGN-EB3 ar trebui s\u0103 fie administrate rapid oric\u0103rei persoane care ia virusul.<\/p>\n
\nCele 2 tratamente au “demonstrat beneficii clare” \u015fi ar putea fi utilizate pentru to\u0163i cei infecta\u0163i de Ebola, inclusiv pentru persoanele \u00een v\u00e2rst\u0103, femeile \u00eens\u0103rcinate \u015fi cele care al\u0103pteaz\u0103, copiii \u015fi nou-n\u0103scu\u0163ii.<\/p>\n
\n“Pacien\u0163ii ar trebui s\u0103 primeasc\u0103 anticorpii monoclonali neutralizan\u0163i recomanda\u0163i c\u00e2t mai cur\u00e2nd posibil dup\u0103 confirmarea de laborator a diagnosticului”, a precizat agen\u0163ia.<\/p>\n
\nOMS a avertizat \u00eens\u0103 c\u0103 accesul la ambele tratamente r\u0103m\u00e2ne “o provocare, \u00een special \u00een zonele cu resurse reduse”.<\/p>\n
\nRobert Fowler, de la Universitatea din Toronto, a salutat “progresele \u00een materie de \u00eengrijire de sus\u0163inere \u015fi terapeutic\u0103 din ultimul deceniu care au revolu\u0163ionat tratamentul Ebola”.<\/p>\n
\n“Boala cu virus Ebola era perceput\u0103 ca fiind un uciga\u015f aproape sigur. Cu toate acestea, acest lucru nu mai este cazul”, a spus el \u00een declara\u0163ie.<\/p>\n
\nCombinate cu un sprijin adecvat, cele dou\u0103 tratamente recomandate \u00eenseamn\u0103 “recuperare pentru marea majoritate a persoanelor”, a mai spus el.<\/p>\n","protected":false},"excerpt":{"rendered":"
Dou\u0103 tratamente existente au redus drastic num\u0103rul de decese cauzate de Ebola \u015fi ar trebui s\u0103 fie administrate persoanelor de toate v\u00e2rstele care sufer\u0103 de aceast\u0103 boal\u0103 hemoragic\u0103, adesea fatal\u0103, spune Organiza\u0163ia Mondial\u0103 a S\u0103n\u0103t\u0103\u0163ii. Public\u00e2nd primele sale orient\u0103ri de p\u00e2n\u0103 acum cu privire la terapiile care trebuie utilizate \u00eempotriva Ebola, OMS a recomandat cu […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[37519,12923],"class_list":["post-207446","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-ebola","tag-tratament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/207446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=207446"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/207446\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=207446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=207446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=207446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}